Latest News

  • Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis Read More
  • Alkermes Announces Settlement With Amneal Over VIVITROL® Patent Dispute Read More
  • Alkermes Plc Reports Second Quarter 2019 Financial Results Read More

Investors

Working at Alkermes